Sign in to fuzzto save your conversations, follow your research and come back anytime.

Praj Industries Limited is an Indian industrial biotechnology company founded in 1985. It specializes in bioprocesses and engineering, providing solutions for the distillery industry and other sectors. The company offers technology, engineering design, equipment, project management, and turnkey projects for bioethanol, biodiesel, wastewater treatment, and brewery operations. Praj has expanded globally, with projects in various countries and subsidiaries in multiple nations. The company has developed several innovative technologies, including BIOSYRUP, EcoCool, MAXIMOL, Celluniti, and enfinity. Praj is involved in renewable transportation fuels, chemicals, and materials through its BioMobility and Bio-Prism platforms. It has also ventured into critical process equipment for industries such as petrochemicals and LNG. The company has commissioned significant projects, including India's first 2G ethanol plant and Asia's largest syrup-to-ethanol plant.
In the news

Gobardhan scheme targets ₹50,000 crore biofuel investment

Praj Industries shares rally 4.45% after Q1 profit more than doubles YoY

₹32,000+ crore CBG scheme targets 10x production boost

Govt E100 push could transform India's ethanol industry

Praj Industries defies market downturn on green tech growth

MarketSmith recommends 5 stocks for April 24 amid market decline

Prabhudas Lilladher sets Praj Industries target at ₹340
The Quarter story
The two most recent quarterly results, compared side-by-side.
Praj Industries shows stabilizing profitability and strong order visibility, though standalone margins face cost pressures and export demand contracts.
Order Backlog grew from ₹43,050 to ₹45,890 from Q4 FY26 to Q1 FY27 — strong revenue visibility ahead
Standalone EBITDA Margin fell from 7.56% to 3.78% from Q3 FY26 to Q1 FY27 — reflecting cost pressures
Order Intake rose from ₹7,950 to ₹10,000 from Q1 FY26 to Q1 FY27 — driving future growth
Export Revenue Share dropped from 39% to 25% from Q1 FY26 to Q1 FY27 — indicating export market contraction
Consolidated EBITDA Margin recovered from 2.76% to 4.19% from Q4 FY26 to Q1 FY27 — stabilizing profitability
Standalone Operating EBITDA declined from ₹602 to ₹204 from Q2 FY26 to Q1 FY27 — showing margin compression
Interest Expense fell from ₹52 to ₹37 from Q4 FY26 to Q1 FY27 — successful debt reduction
Standalone Interest Cost rose from ₹15 to ₹62 from Q1 FY26 to Q4 FY26 — reflecting increased borrowing costs
Domestic Revenue Share climbed from 61% to 75% from Q1 FY26 to Q1 FY27 — confirming domestic market dominance
Standalone Expenses surged from ₹4,823 to ₹24,113 from Q1 FY26 to Q4 FY26 — indicating aggressive project execution spend